Verseon

Verseon

A technology-based pharmaceutical company developing novel therapeutics for today’s challenging diseases.
Industry: Biotechnology | Jurisdiction: United States
Pending

Video

8.00

STOWise Rating

You need to login in order to vote

Token Sale

  • Private Sale Start
  • Private Sale End
  • Token Supply
  • Price

  • Pre-Sale Start
  • Pre-Sale End
  • Token Supply
  • Price

  • STO Sale Start
  • STO Sale End
  • Token Supply
  • Price

  • Accepted Currencies
  • Offering Size
  • Minimum Investment

Token Details

  • Token Name
  • Token Symbol
  • Token Price
  • Blockchain Platform Ethereum
  • Issuance Platform Blockrules
  • Standard PENDING
  • Contract Address
  • Token Symbol
  • Registration Country United States
  • Restriction - KYC Yes
  • Restriction - Whitelist No


Offering Details

  • Offering Type Revenue Share
  • Token Benefits & Rights: Revenue Share Right

Offering Terms Description:

Token Distribution Details:

Proceeds Allocation:

Company Profile

  • Corporation Name Verseon Corporation
  • Company Type Corporation
  • Country of Incorporation United States
  • Date of Incorporation 06/08/2007

Address:

47071 Bayside Parkway

Fremont,CA
United States

  • Phone +1.510.225.9000
  • Email info@verseon.com

Company Verifications

  • CIK# 0001348948
  • CRD#
  • SEC#
  • CUSIP#
  • ISIN# USU9221J1098

STO Partners

BlockRules


Company Management

Name Title Linkedin
Adityo PrakashCEO, Founder
Eniko FodorCOO, Founder
David Kita, FounderVice President of R&D
David WilliamsSenior Director of Platform Technology
Anirban DattaSenior Director of Discovery Biology

Advisors

Name Title Linkedin
Steven ChuAdvisor
John LeonardAdvisor

Notes

Listed on the AIM market of the London Stock Exchange.
We have successfully changed our LSE ticker to VERS a few weeks ago.

Facebook

......

Leave a Reply